Diabetes & Metabolism

Papers
(The H4-Index of Diabetes & Metabolism is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Contents - page 1100
Analysis of glycemic control in diabetic patients by monitoring HbA1c levels before, during and after Covid-19 confinement in Auvergne, France81
Diuretics and risk of major adverse limb events in patients with type-2 diabetes: An observational retrospective study74
Editorial board50
Are GLP-1 receptor agonists and diabetic retinopathy foes or friends?42
Dapagliflozin reduces adiposity and increases adiponectin in patients with type 2 diabetes and atherosclerotic disease at short-term: An active-controlled randomised trial41
Discontinuation of hemodialysis after correction of a major hypothyroidism episode, A case report38
Contents36
Cost analysis of continuous glucose monitoring in patients hospitalized in a diabetes department36
Editorial board35
Association between adipose deposition and mortality among adults without major cardiovascular risk factors34
The significance of ophthalmological evaluation in the correct diagnosis of pediatric insulin-dependent diabetes mellitus: lessons from novel WFS1 variants33
Associations of young onset age and genetic risk of beta cell dysfunction with glycaemic progression in individuals with type 2 diabetes31
Body weight trends in individuals with type 1 diabetes using automated insulin delivery vs. traditional insulin pumps31
Diabetic retinopathy remission in patients using an automated insulin delivery system: A prospective controlled study30
Early life Bacillus Calmette-Guerin vaccination and incidence of type 1, type 2, and latent autoimmune diabetes in adulthood30
Reduced risks of colorectal cancer with GLP-1RAs in type 2 diabetes: A nationwide cohort study using a target trial emulation framework30
Prevalence and incidence of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: A nationwide French observational study of hospitalized patients30
Mitochondrial heteroplasmy-phenotype correlation and response to glucose lowering therapy in subjects with m.3243A>G mutations29
Comment on “Elevated triglyceride–glucose index predicts risk of incident ischemic stroke: The Rural Chinese cohort study”26
Eleven-year trends in socioeconomic inequalities in the prevalence and incidence of pharmacologically treated type 2 diabetes in France, 2010–202026
Obesity rather than diabetes impacted severe Covid-19 on reunion island: A retrospective cohort study from a frontline hospital, 2020–202126
Screening strategies for glucose tolerance abnormalities and diabetes in people with cystic fibrosis26
Concise review of lipidomics in nonalcoholic fatty liver disease25
Association between metabolic dysfunction-associated fatty liver disease and supraventricular and ventricular tachyarrhythmias in patients with type 2 diabetes25
Effects of SGLT2 inhibitors on clinical cancer survival in patients with type 2 diabetes25
0.054190158843994